| Metric | Value ($ M) | Q1 FY26 | Q2 FY25 |
|---|---|---|---|
| Revenue | 5.6K | 4.8% | 6.8% |
| Total Income | 5.6K | 4.8% | 6.8% |
| Expenditure | 4.1K | 1.4% | 7.2% |
| PBT | — | ||
| Net Profit | 826.00 | 17.7% | 186.8% |
| OPM | 26.67% | 2.53pp | 11.06pp |
| NPM | 14.68% | 1.60pp | 9.21pp |
| EPS | 9.89 | 22.3% | 213.0% |
Tenet Healthcare Reports Strong Second Quarter 2026 Results; Raises 2026 Financial Outlook
24 Jul 2026 · 24 Jul, 1:43 am
Summary
Tenet Healthcare Corporation reported strong financial results for the second quarter of 2026, with net income available to common shareholders reaching $826 million, up significantly from $288 million in the prior year. Adjusted diluted earnings per share saw a substantial increase of 52.2% to $6.12. Consolidated Adjusted EBITDA grew 16.3% to $1.304 billion, and the company raised its full-year 2026 financial outlook for both Adjusted EBITDA and Adjusted Free Cash Flow. Management highlighted strong same-store revenue growth and effective expense management as key drivers for the outperformance.
Key Highlights
- 1
Net income available to common shareholders in the second quarter of 2026 was $826 million, or $9.84 per diluted share, a significant increase from $288 million, or $3.14 per diluted share, in the second quarter of 2025.
- 2
Adjusted diluted earnings per share increased by 52.2% to $6.12 in the second quarter of 2026, compared to $4.02 in the same period of 2025.
- 3
Consolidated Adjusted EBITDA for the second quarter of 2026 rose by 16.3% year-over-year to $1.304 billion, with an Adjusted EBITDA margin of 23.2%.
- 4
The Hospital segment's Adjusted EBITDA margin improved to 18.0% in the second quarter of 2026 from 15.6% in the prior year's second quarter, despite headwinds.
- 5
The Company's Board of Directors authorized a $2.0 billion increase to the share repurchase program, bringing the total remaining authorization to $2.13 billion.
- 6
The full-year 2026 Adjusted EBITDA outlook was raised to a range of $4.83 billion to $5.03 billion, an increase of $295 million at the midpoint.
- 7
The full-year 2026 Adjusted Free Cash Flow outlook was also increased to a range of $2.725 billion to $3.025 billion, a $225 million increase at the midpoint.
Management Comments
Saum Sutaria
Strong same-store revenue growth and effective expense management drove our fundamental outperformance in the second quarter of 2026 compared to our original assumptions. We are actively navigating current industry dynamics through excellent operational execution, investments in innovation, and a continued focus on higher acuity services to sustain growth, margins and significant free cash flow.
Informational and educational content only. Not investment advice.